Jobs / United States / Sanofi US Services INC
Senior Director, New Product Planning – Neurology
Sanofi US Services INC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Sanofi US Services INC paid sponsored hires in similar roles2 certified filings for “Associate Director” (Regulatory Affairs Managers) in MA: $147k–$147k, median $147k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Sanofi US Services INC
The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Sanofi US Services INC →
About the role
Job Title: Senior Director, New Product Planning – Neurology • Location: Cambridge, MA or Morristown, NJ About the Job Join a team transforming the vision of care for people with neurological conditions. In Sanofi’s Specialty Care you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. Reporting to the Global Head of New Product Planning (NPP) for the Sanofi Neurology Franchise, the Senior Director NPP Neurology will play a critical role in the future growth of Sanofi. This role demands a deep understanding of commercialization needs throughout pre-launch, ensuring that early-stage assets are developed with commercial viability, market readiness and probability of overall success in mind. The Senior Director will: • Leverage deep understanding of major global pharmaceutical markets, strong analytical skills and previous commercialization experience to lead the commercial strategy and brand development for internal neurology pipeline drug candidates from discovery/preclinical through proof of concept/start of phase 3. • Lead the commercial Due Diligence and assessment of external pipeline opportunities (In-licensing, collaborations, M&A). • Coordinate and support the development and articulation of comprehensive Therapeutic Area and Disease Area strategy projects. The Senior Director NPP Neurology will collaborate cross-functionally with teams and leaders across the organization including Research, Clinical Development, Regulatory, Medical, Business Operations, Commercial, R&D Portfolio Strategy and Business Development. In particular, the Senior Director NPP Neurology will closely partner with SILC, Market Access, Health Economics, Forecasting, Market Research and Competitive Intelligence to deliver the commercial assessments and strategies. Join the team transforming care for people with immune challenges, rare diseases, cancers, and Specialty Care neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives. Main responsibilities: Drive Therapeutic Area and Disease Area Strategy development and execution: • Lead and drive the development of the Neurology TAS ensuring submission of an aligned and clear articulation of the strategy across Research, Clinical Development and Commercial, working closely with Neurology Therapeutics Areas Strategy (TAS) core team; liaise with Function Heads, Corporate Strategy, R&D Strategy, TA Heads, GBLs and GPHs. • Support the preparation of the annual Portfolio Strategy Week (PSW) presentation and Disease Area Strategy (DAS) requirements. • Analyze disease landscapes, identify investment opportunities, develop recommendations and execution roadmaps. • Present strategic assessments and recommendations to Senior Leadership, including ExCom members. Advance early pipeline and guide drug development with future commercialization in mind: • Represent commercial as a core member of the Global Project Team (GPT), leading the development of Target Product Profiles (TPP) based on thorough understanding of market dynamics and targeted differentiation and positioning. • Support the team in preparing strategic assessments and deliverables, including presentations, to governance committees. • Actively participate in the development of a robust asset-specific